(Q44351368)

English

Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy

scientific article published in January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Eisen D

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Essell J

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Broun ER

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sigmund D

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

DeVoe M

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

51-55

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703817

0 references

Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Oral and pharyngeal herpes simplex virus infection after allogeneic bone marrow transplantation: analysis of factors associated with infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Implementation and evaluation of a standardized herpes simplex virus prophylaxis protocol on a leukemia/bone marrow transplant unit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Oral cavity complications of bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Acyclovir prophylaxis of herpes-simplex-virus infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Adverse effects and drug interactions of clinical importance with antiviral drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Thrombotic microangiopathies and HIV infection: report of two typical cases, features of HUS and TTP, and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Infections in cancer patients: some controversial issues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Is aciclovir prophylaxis necessary after bone marrow transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Herpes simplex virus resistant to acyclovir. A study in a tertiary care center

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

21 January 2018

The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

7 January 2021

based on heuristic

inferred from DOI database lookup

Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

7 January 2021

based on heuristic

inferred from DOI database lookup

The Albion Street Centre database, Sydney, Australia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703817

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703817

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44351368&oldid=2109651156"